The influence of L-carnitine supplementation on hematocrit and hemoglobin levels in patients with end stage renal failure on CAPD

Renal Failure

Volumn 24, Issue 4, 2002, Pages 505-510

  Sotirakopoulos, Nikolaos ^a   Athanasiou, George ^b   Tsitsios, Telemachos ^a   Mavromatidis, Konstantinos ^c  

^a General Hospital of Komotini   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c NONE

Author keywords

CAPD; Hematocrit; L Carnitine; Recombinant erythropoietin; Renal failure

Indexed keywords

CARNITINE; FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN; SUPERAMIN; FERRIC ION; HEMOGLOBIN; IRON POLYMALTOSE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; BLOOD; CHRONIC KIDNEY FAILURE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CARNITINE; FEMALE; FERRIC COMPOUNDS; FERRITIN; HEMATOCRIT; HEMOGLOBINS; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; FERRITINS; HUMANS; MIDDLE AGED;

EID: 0035994250     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120006777     Document Type: Article

References (14)

1. Blood loss during maintenance hemodialysis
2. Recombinant human erythropoietin and renal anemia: Molecular biology, clinical efficacy and nervous system effects
3. Inflammation, serum C-reactive protein and erythropoietin resistance
4. Lipids and hematocrit after long-term L-carnitine treatment in hemodialysis
5. Effect of L-carnitine supplementation on red blood cells deformability in hemodialysis patients
6. Continuous ambulatory peritoneal dialysis (CAPD) adequacy influences serum free carnitine level
7. Filterability of subpopulation of leukocytes. Effect of pentoxyfylline
8. Carnitine
9. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration
10. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients
11. L-carnitine effect on anemia in hemodialysis patients treated with erythropoietin
12. Addition of L-carnitine to additive solution-suspended red cells stored at 4°C reduces in vitro hemolysis and improves in vivo viability
13. Low dose of L-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients
14. Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis